Biotop-report 2011
Yüklə 0,8 Mb. Pdf görüntüsü
|
- Bu səhifədəki naviqasiya:
- Innovation for better health.
- Dr. Kai Bindseil
| 1 B i o T O P i c s 4 2 _ B i o T O P R e p o r t 2 0 1 1 Journal of Biotechnology in Berlin-Brandenburg Issue 42 · June 2011
2 B i o T O P i c s 4 2 _ B i o T O P R e p o r t 2 0 1 1
bring to patients around the world quality medicines for use in diagnosing, combating and preventing disease. Every day we work against time, researching new pathways, new molecules, new technologies – complementing our own capabilities with exper tise of innovative partners from science and industry. The success of this work is evidenced in new med i cines for areas with significant unmet medical need such as oncology, cardiovascular and blood diseases, as well as gynecology and molecular imaging. Our aim is a better quality of life for all. Bayer – Science For A Better Life. You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it. www.bayerhealthcarepharmaceuticals.com www.bayerhealthcare.com 29407004_BHC_Imageanzeige_210x297mm_engl_RZ.indd 1 28.02.11 14:32
3 B i o T O P i c s 4 2 _ B i o T O P R e p o r t 2 0 1 1 Content
Publisher: BioTOP Berlin-Brandenburg
Fasanenstraße 85 · D-10623 Berlin Phone +49 30 318622-0
Fax
+49 30 318622-22
biotop@biotop.de · www.biotop.de Editor: Thilo Spahl Design & Production: supiran.de Translation: Textbüro Reul GmbH · Frankfurt Photos: p.4: Stephanie Eißrig p.8: World Health Summit p.13: Helmholtz-Zentrum Geesthacht p.17: Christoph Heidrich p.26: Leibniz-Institut für Agrartechnik Potsdam-Bornim e. V. p.30: Peitz, Charité – Universitätsmedizin Berlin p. 42 (left): Rustam Shanov | Dreamstime.com p.43: Heike Zappe p.44: Berlin Partner GmbH Others: Authors or BioTOP BioTOP is a joint initiative of the state of Berlin and the state of Brandenburg under the umbrella of the TSB Innovationsagentur Berlin GmbH and part of the cluster management Health Capital. BioTOP is funded by the federal state of Berlin, the federal state of Brandenburg and the Investitionsbank Berlin, cofunded by the European Union (European Fund for Regional Development). The BioCapital Region 5 A Reputation for Excellence in Life Sciences 6 Exploring the Regenerative Potential of the Human Body 12 In Vitro-Diagnostics for the World Market 16 Excellence in Drug Discovery and Development 22 Technologies for the Bio-Based Economy 26 Returning to Growth 28 Surprising Turnaround in VC Financing 36 The BioCampus Network Berlin-Brandenburg 38 From Basics to Very Special Things 42 Excellent Corporate Locating and Project Development Services 44 Addresses 47 Innovation for better health. Our commitment is to bring to patients around the world quality medicines for use in diagnosing, combating and preventing disease. Every day we work against time, researching new pathways, new molecules, new technologies – complementing our own capabilities with exper tise of innovative partners from science and industry. The success of this work is evidenced in new med i cines for areas with significant unmet medical need such as oncology, cardiovascular and blood diseases, as well as gynecology and molecular imaging. Our aim is a better quality of life for all. Bayer – Science For A Better Life. You need commitment, focus and passion to find new ways to fight the diseases of this world: innovation is at the heart of it. www.bayerhealthcarepharmaceuticals.com www.bayerhealthcare.com 29407004_BHC_Imageanzeige_210x297mm_engl_RZ.indd 1 28.02.11 14:32
4 Deutsche Biotechnologietage 2010 In April 2010 the first “German Biotechnology Days” took place in Berlin. The important national event for the biotechnology industry attracted more than 600 participants, who discussed the major trends affecting the industry. B i o T O P i c s 4 2 _ B i o T O P R e p o r t 2 0 1 1
5 B i o T O P i c s 4 2 _ B i o T O P R e p o r t 2 0 1 1 10 years ago, in Feb- ruary 2001, BioTOP published the first of its yearly reports on the life sciences sector denburg. In this first report we described technology fields that seemed most promis- ing to us, and we pre- dicted rapid growth in employment in the years to come. Today we are happy to state that Berlin-Brandenburg is very well positioned in many of the fields we had identified as strengths that were to be developed. For glycobiotechology the region has become the place to be. It is home of world renowned researchers, for instance at the Max Planck Institute of Colloids and Interfaces, and leading companies like Gly- cotope. Tissue Engineering has become an important constituent of regenerative medicine, and with the Ber- lin Brandenburg Center for Regenerative Therapies the region has earned worldwide reputation in this dynamic field. Biohybrid technologies that were originally devel- oped at the University of Potsdam are today a basis of our rapidly developing diagnostic industry. So biotechnology has really become one of the big assets of the region. We must however admit that – like many others - we were too optimistic in our expectations of economic growth. Exponential growth could not be achieved in the years after the millennium bubble and during the financial crises of the last years. Nevertheless the number of jobs in biotech companies has doubled in the last decade, and pharma giants like Bayer, Sanofi-Aventis and Pfizer have come to Berlin. The BioTOP Report 2011 presents most recent develop- ments in the region and an overview of the companies and research facilities located here. In 2010 companies returned to their accustomed growth levels again. After the economy had been more or less stagnant during the year 2009, the region is now showing splendid 4.7 % growth - a clear sign of the region’s economic dyna- mism. In terms of scientific and technological progress there are many encouraging developments, especially in the fields of diagnostics, drug development, regenera- tive medicine and industrial biotechnology. BioTOP is proud to support this development as the cen- tral network node and your first contact. Based on our expertise, our direct contacts with industry and aca- demia and our extended network we are continuously servicing the biotech industry in all questions regarding infrastructure, financing, tech transfer, human resources and business development. We would like to thank everyone whose commitment has contributed to mak- ing Berlin-Brandenburg a hotspot where scientific excel- lence drives economic growth, not just in biotechnology but in many other areas of our young knowledge-based industry. We welcome everyone with ideas, plans and visions, personal ambition and a desire to play a part in the suc- cess of this great region. Feel free to get in touch with us any time!
Director BioTOP Berlin-Brandenburg Germany’s capital region is among Europe’s leading hubs for biotechnology and pharma. This success is based on the excellence of the research institutes in our region, the innova- tive power of the companies located here, and the close links between science and industry that have evolved. No less than five universities, four universities of applied scienc es, 19 major research institutes, 200 biotech- and 23 pharma companies are engaged in research and development of new high-tech products.
Yüklə 0,8 Mb. Dostları ilə paylaş:
|